BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19664568)

  • 61. A prospective observational study of treatment practice patterns in acute coronary syndrome patients undergoing percutaneous coronary intervention in Europe.
    Ferrières J; Sartral M; Tcherny-Lessenot S; Belger M;
    Arch Cardiovasc Dis; 2011 Feb; 104(2):104-14. PubMed ID: 21402345
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fine-tuning therapy for acute coronary syndromes.
    Fuster V
    N Engl J Med; 2010 Sep; 363(10):976-7. PubMed ID: 20818910
    [No Abstract]   [Full Text] [Related]  

  • 63. Competing pharmacological strategies during PCI-analysis of a prematurely terminated trial.
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):1010-1. PubMed ID: 21598352
    [No Abstract]   [Full Text] [Related]  

  • 64. Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement.
    Gawaz M; Seyfarth M; Müller I; Rüdiger S; Pogatsa-Murray G; Wolf B; Schömig A
    Am J Cardiol; 2001 Feb; 87(3):332-6, A9. PubMed ID: 11165971
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is clopidogrel adequate in 2013?
    Wheatcroft S
    Cardiovasc J Afr; 2013 Mar; 24(2):45. PubMed ID: 23750347
    [No Abstract]   [Full Text] [Related]  

  • 66. Clopidogrel in acute coronary syndromes.
    Chua D; Ignaszewski A
    BMJ; 2009 Apr; 338():b1180. PubMed ID: 19366756
    [No Abstract]   [Full Text] [Related]  

  • 67. The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy.
    Scirica BM; Cannon CP; Emanuelsson H; Michelson EL; Harrington RA; Husted S; James S; Katus H; Pais P; Raev D; Spinar J; Steg PG; Storey RF; Wallentin L;
    J Am Coll Cardiol; 2011 May; 57(19):1908-16. PubMed ID: 21545948
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Summaries for patients. What aspirin dose is safest and most effective for preventing heart disease?
    Ann Intern Med; 2009 Mar; 150(6):I-22. PubMed ID: 19293067
    [No Abstract]   [Full Text] [Related]  

  • 69. Dosing of clopidogrel and aspirin in acute coronary syndromes.
    Merella P; Casu G; Meloni I
    N Engl J Med; 2010 Dec; 363(25):2466-7; author reply 2467-8. PubMed ID: 21158665
    [No Abstract]   [Full Text] [Related]  

  • 70. Short Communication: Evaluation of nephrotoxicity by aspirin-clopidogrel combination therapy in patients with acute coronary syndrome.
    Qadir MI; Rehman A; HamidAkash MS; Irfan M; Baber M; Hussain SB
    Pak J Pharm Sci; 2016 Nov; 29(6):2103-2104. PubMed ID: 28375131
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Summaries for patients. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.
    Ann Intern Med; 2009 Mar; 150(6):I-37. PubMed ID: 19293068
    [No Abstract]   [Full Text] [Related]  

  • 72. Dosing of clopidogrel and aspirin in acute coronary syndromes.
    Padrini R; Pengo V
    N Engl J Med; 2010 Dec; 363(25):2465-6; author reply 2467-8. PubMed ID: 21158667
    [No Abstract]   [Full Text] [Related]  

  • 73. Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation.
    Ruiz-Nodar JM; Marín F; Lip GY
    JACC Cardiovasc Interv; 2008 Jun; 1(3):329; author reply 330-1. PubMed ID: 19463322
    [No Abstract]   [Full Text] [Related]  

  • 74. Low mean corpuscular hemoglobin level is a predictor of discontinuation of antiplatelet therapy in patients with acute coronary syndrome.
    Ishida M; Watanabe H; Iino K; Okawa M; Kosaka T; Ito H
    Intern Med; 2011; 50(24):2933-9. PubMed ID: 22185982
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Surgery shortly after stent implantation?].
    Er F
    Dtsch Med Wochenschr; 2012 Sep; 137(39):1934. PubMed ID: 22996583
    [No Abstract]   [Full Text] [Related]  

  • 76. [Perioperative discontinuation of antiplatelet therapy of patients with coronary stents. Reevaluating the risks].
    Graw J; Schwenk W; Volk T
    Chirurg; 2009 Jun; 80(6):498-501. PubMed ID: 19011817
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dual antiplatelet therapy plus oral anticoagulation: how does hemorrhagic risk impact stent selection?
    Giugliano GR; Lotfi AS
    JACC Cardiovasc Interv; 2008 Jun; 1(3):330; author reply 330-1. PubMed ID: 19463324
    [No Abstract]   [Full Text] [Related]  

  • 78. Double-dose clopidogrel in patients undergoing PCI for ACS.
    Schiele F
    Lancet; 2011 Jan; 377(9762):297; author reply 298. PubMed ID: 21256376
    [No Abstract]   [Full Text] [Related]  

  • 79. Here today, gone today: time for same-day discharge after PCI.
    Blankenship JC
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):626-8. PubMed ID: 18949777
    [No Abstract]   [Full Text] [Related]  

  • 80. Double-dose clopidogrel in patients undergoing PCI for ACS.
    Vassiliou V
    Lancet; 2011 Jan; 377(9762):297; author reply 298. PubMed ID: 21256377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.